Investigating the mutations driving non Hodgkin lymphomas and developing plasma-based assays for tumour detection and monitoring

研究驱动非霍奇金淋巴瘤的突变并开发基于血浆的肿瘤检测和监测检测方法

• 批准号: 293709
• 负责人: Morin Ryan D
• 金额: $ 0.07万
• 依托单位: Simon Fraser University (Burnaby, B.C.)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2013
• 资助国家: 加拿大
• 起止时间: 2013-03-01 至 2014-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=293709&lang=en
• 关键词: Biomarkers; Drug Targets; Genomics; Non Hodgkin Lymphoma; Sequencing; Somatic Mutations

Lymphomas are a diverse and complex collection of cancers that all arise from cells of our immune system. Some lymphomas are indolent, meaning they grow slowly and result in few symptoms, whereas others are aggressive and can lead to death in a short amou

淋巴瘤是一种多样而复杂的癌症集合，它们都来自我们免疫系统的细胞。有些淋巴瘤是惰性的，这意味着它们生长缓慢，导致很少的症状，而另一些是积极的，并可能导致死亡在短期内。